Responses used to more robustly define the number of patients with pre-referral consultations, i.e. to exclude patients who in response to QWHERE they indicated that they had first sought help from the GP, but in response to QVISIT1 indicated that they had not visited the GP before being referred, n = 125). Number of pre-referral consultations at given care facility "How many times did you go <pull through response from QVISIT> before you were diagnosed?" (QNUMVISIT1)
Enter number between 1 and 40; or 'don't know/can't remember' Response used to define number of prereferral GP consultations (after excluding contradictory responses -see row above). *Available here: https://xip.uclb.com/i/healthcare_tools/brightlight_wave1.html, under licence. Lines 67-74: Some evidence suggests that young people experience a longer time from symptom onset to diagnosis compared to children and older adults. 4, [6] [7] [8] [9] However, the evidence is difficult to interpret and inconclusive as comparable studies are rare. Prolonged intervals to diagnosis can adversely affect clinical outcomes, decrease confidence of patients and parents in their doctors and are associated with a poorer experience of subsequent cancer care.
10, 11 Despite this, diagnostic timeliness in AYA is not well quantified and the identification of high-risk groups remains elusive.
Lines 88-91:
We aimed to examine diagnostic timeliness of cancer in a cohort of young people, to identify factors associated with longer diagnostic journeys and produce evidence to inform interventions supporting earlier diagnosis and improvement of subsequent outcomes. Lines 159-160: 'We also described the numbers and proportions of patients with 3+ pre-referral GP consultations, as this is associated with the length of primary care interval' Lines 174-184: For our two categorical outcomes (i.e. patient interval, and 3+ pre-referral GP consultations), we fitted multivariable logistic regression models. We re-categorised the patient interval as a binary variable (<1 month vs. 1 month+) for analytical and interpretational convenience, informed by prior relevant studies in adult patients. 23, 24 'We opted for a one month cut-off, deeming this long enough to be clinically important, and taking into consideration that public health education campaigns about awareness of cancer symptoms typically use a cut-off of 3 weeks for chronic symptoms.' We treated the number of pre-referral consultations as a binary outcome (<3 vs. 3+), consistent with public reporting conventions of the National Cancer Patient Experience Survey,25 and given that some second appointments could reflect the need to review the findings of investigations ordered at initial consultation. Table 1 ).
Lines 103-112: BRIGHTLIGHT recruited 1,114 participants within four months of cancer diagnosis from 96 National Health Service Trusts hospitals across England which deliver free universal healthcare to all patients in their geographical catchment. Of those recruited, 830 completed a faceto-face interview within five months of diagnosis. Reasons for study drop out between consent and interview included early death, refusal, and being too ill to take part; these participants were not atypical to those who remained in the study (Supplementary Figure S1) . A full description of the BRIGHTLIGHT cohort will be reported separately. Once lLocal treatment teams gained consent from young people agreed to participate in the study, and then young people were contacted by the survey provider (Ipsos MORI) to undertake a structured interview.
Numbers analysed are described within Tables 2-4 In 'Methods', we reference the BRIGHTLIGHT website which provides links further describing derivation of the cohort. see figure S1 Flow chart of BRIGHTLIGHT participants Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders These are described in Table 1 .
(b) Indicate number of participants with missing data for each variable of interest These are described in Table 1, and as footnotes to Tables 2-4 We examined diagnostic timeliness and related it to variation by sociodemographic characteristics and cancer site. Compared to males, females were more likely to have multiple prereferral GP consultations and the longest average symptom-onset-to-diagnosis interval. Further study is needed into causes underlying these patterns. There was large variation by cancer site in all aspects of diagnostic timeliness studied. AYA with melanoma were most likely to wait over a month before seeking help about their symptoms, but were the least likely to have multiple pre-referral consultations, consistent with the readily identifiable clinical features of this cancer. Patients with lymphoma or bone tumours were most likely to have multiple pre-referral consultations, reflecting the often less-specific presenting features. The average time from first symptom to diagnosis was longest for bone tumours and shortest for leukaemia Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. Limitations discussed in lines 312-358. Sources of potential bias: missing data, inaccuracy of recall of first symptom. Implications discussed in lines 282-285:
Sources of potential bias: missing data, inaccuracy of recall of first symptom. Implications discussed in lines 323-3265: while on average diagnostic timeliness in invited patients and those in the analysis sample may differ , it is generally accepted in survey research that the patterns of variation in the studied outcomes by patient characteristics are unlikely to differ And lines 333-338 Such differences in recall could result in more accurate estimates about the diagnostic timeliness of cancer sites associated with specific symptoms, such as melanoma or male germ cell cancers, and the potential for inaccuracy for cancer sites associated with symptoms of relatively low predictive value. Nevertheless, we observe sufficient evidence for variation for some of these latter sites (leukaemia, germ cell tumours, and bone tumours), although these associations may have been under-estimated.
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence Lines 315-319 Survey participants were generally representative of incident cancer cases, and patient interviews were carried out relatively close to the time of diagnosis (on average within six months), minimising concerns about potential survivorship bias (whereby patient groups with high risk of mortality post-diagnosis are under-represented among surveyed participants), or recall bias.
Lines 323-326: "…Further, while on average diagnostic timeliness in invited patients and those in the analysis sample may differ , it is generally accepted in survey research that the patterns of variation in the studied outcomes by patient characteristics are unlikely to differ. 26 "
Lines 296-298: Diagnostic timeliness of AYA in this study was poorer compared to that reported for children or older adults with cancer.
Lines 345-350: " Despite the fact that our sample size is the largest study to date of patient-reported diagnostic timeliness for AYA, the number of categories in certain variables (e.g. the number of cancer site groups, and therefore the number of cancer-gender-age-deprivation-ethnicity strata in multivariable models) means that certain estimates of associations lack precision. In such circumstances focusing on overall patterns of variation between categories rather than categoryspecific estimates is preferable Generalisability 21 Discuss the generalisability (external validity) of the study results Core Data: Brightlight survey data, linked to case report forms (CRFs).
III.
Background There is evidence that there is variation in the length of different diagnostic intervals (from symptom to presentation ['patient interval'], from presentation to referral ['primary care interval'], from referral to diagnosis ['system interval']) for adult cancer patients (1), according to socio-demographic characteristics such as age and sex, and type of cancer (2-4). However, this variation has not yet been characterised in children and young people. The distribution of cancer types in this population is different to that in adults; it is likely that so is the variation in lengths of diagnostic intervals. We propose to explore variation in lengths of diagnostic intervals in children and young people by socio-demographic characteristics and types of cancer, to highlight any missed opportunities for a more timely diagnosis.
IV.
Main Question(s) What is the variation in pre-diagnostic intervals for teenagers and young adults? How much of this variation is accounted for by socio-demographic factors?
V.
Data to be used Dependent variable: Patient-, Primary Care-and system-, intervals (derived from survey variables QDIAG, QSEEKH, QWAIT3, and histological date of diagnosis [CRF]) Independent variable and control variables: sex (CRF), age at diagnosis (CRF), ethnicity (QETHNIC), socioeconomic status (Index of Multiple Deprivation from CRF), marital status (QMARSTAT; for those 16y+), employment status (QEMPLOY1; for those 16y+), and cancer site (QCANCER).
VI.
Analytic plan For each combination of socio-demographic characteristics and type of cancer, we will present descriptive statistics of the patient, primary care and system intervals (median and other centiles). We will explore the association of these independent variables with each outcome by fitting quantile regression models (which will account for the likely positive skew of outcomes).
